Hospitals to pay price for failure to innovate

Patients to be told if health authorities blacklist latest drugs

Patients across the country will soon be able to see whether their local hospital or health authority is rationing care as part of government plans to eradicate "postcode prescribing" in the NHS.

From this autumn, every hospital and commissioning body in England will be forced to start publishing statistics showing how many of its patients are being provided with the latest drugs and treatments recommended by the National Institute for Health and Clinical Excellence (Nice). The move will mean that, by next year, every hospital and health trust will be rated using an "innovation scorecard" allowing patients to compare services and treatments offered in different parts of the country.

Those health authorities found to be denying approved treatments are likely to face censure from the Department of Health.

The plans are due to be announced by the head of the NHS, Sir David Nicholson, next month, The Independent understands. At first the "scorecard" is likely to be made up of around 20 key treatments and interventions where uptake across the NHS is known to be inconsistent. It is expected to be expanded over time to include all new drugs recommended by Nice for widespread use in the NHS.

Ministers hope that the move will bring an end to the problem of "postcode prescribing" where health authorities deliberately restrict access to approved drugs to save money.

Last year it emerged that about a quarter of primary care trusts were blacklisting more expensive drugs in favour of cheaper generic versions, which are sometimes not as effective. Among those banned in some areas were Lipitor and Crestor, two branded statins for cutting cholesterol in people at raised risk of strokes.

Three weeks ago Sir Michael Rawlins, the chairman of Nice, accused trusts of "messing around with the law". "They want to use their money for other purposes: I understand that. But the law is the law, and ... the law clearly says that when Nice gives a positive view of a drug, patients are entitled to it if their doctors think it is appropriate," he said.

Announcing the move, the Health minister Paul Burstow, pictured, said allowing patients to see where drugs were being restricted would be a key catalyst for change. "Patients have a right to drugs and treatments that have been approved by Nice.

"NHS organisations must make sure the latest Nice-approved treatments are available in their area, and if they are not, then they will now be responsible for explaining why not.

"Being transparent with data like this is the hallmark of a 21st-century NHS. It is a fundamental tool to help healthcare professionals improve care."

Sir Andrew Dillon, chief executive of Nice, said the organisation has been working with the NHS Information Centre on drawing up a scorecard of around 20 indicators to assess how NHS organisations were adopting Nice appraisals.

He said the intention was to launch the scorecard in September and it would act as a "benchmark on expected levels of uptake" which would be relevant to patients, doctors and commissioners.

"This is a step change in the detail with which we will be able to see how trusts respond to our recommendations," he said.

"It will be valuable not just to patients but also help hospitals assess how well they're performing and ensure that best practice is disseminated across the NHS."

Sir Andrew added that, in the past, there had been numerous barriers to uptake of new drugs – sometimes financial but often organisational.

"We know that changing professional practice can take time. Doctors, although positively orientated, nevertheless take time to be made aware of the benefits of new treatments for patients.

"What we hope is that the scorecard will help rapidly get a consistent response to national guidance."

But hospital managers expressed some concern that the new system could be bureaucratic and warned that they were facing financial constraints which limited their room for manoeuvre.

David Stout, deputy chief executive of the NHS Confederation, said, "It is important that any new measures do not lead to unnecessary bureaucracy or a duplication of information with no real benefits for hospitals, GPs or patients.

"It is also important to remember that the NHS is facing an unprecedented financial challenge and organisations must live within their means while providing high-quality care.

"We can only afford to provide new drugs where they are cost-effective and demonstrably add real patient benefits. In a health system with no financial growth, any new costs have to be offset by savings elsewhere."

Katherine Murphy, chief executive of the Patients Association, said it would be crucial the information be made available in a format that was meaningful to patients. "They must be in a position to hold the NHS to account because at the moment that doesn't happen. We know the NHS is hopeless at introducing new ideas."

Clare Gerada, president of the Royal College of GPs, said that, while she supported the aims of the scheme, she was sceptical about how effective a scorecard would be. "Will it be a bureaucratic tickbox or will it be something more sensible?" she asked.

Rationing care: Not everybody gets the best treatment

IVF

Despite the publication of Nice guidelines in 2004, patients have experienced inconsistent access to IVF on the NHS, with trusts ruling that some women are too old, too young or have not been with their partner for long enough. Last year, a married couple from Portsmouth who had tried unsuccessfully for a baby for more than three years and were repeatedly refused IVF funding by Portsmouth City PCT won a rare legal victory to secure treatment. They had originally been denied because the husband had a child from a previous marriage.

MS

In an attempt to cut costs Rachelle Ledsam, a 45-year-old MS sufferer, was denied a treat-ment known as Functional Electrical Stimulation – which uses electric currents to re-activate nerves connected to a parlaysed muscle – by her local health board even though it was recommended by NICE. She said the treatment "offers a glimmer of hope and to snatch it away is diabolical".

Gastric bypass

There has been inconsistent application of Nice guidelines on the provision of gastric bypass surgery. Some people in North Staffordshire, for example, have only been able to get treatment if they had a BMI index of more than 50, despite the watchdog's recommendation that it be made available to those 15-points lighter on the obesity scale. Tom Condliff, a 62-year-old former policeman who suffers from diabetes, became the first man in Britain to take legal action against his primary care trust after they denied him the surgery. "It makes me feel very angry and upset," he said. "I live less than a mile from Stoke-on-Trent PCT, which follows the Nice guidelines. If I lived there, I would have had this lifesaving operation years ago."

Treatment of arthritis, heart attacks and strokes

In 2011 it was revealed that around a quarter of primary care trusts were blacklisting some more expensive drugs in favour of cheaper versions. Some had banned Lipitor and Crestor, statins that cut cholesterol in people at raised risk of heart disease and stroke. Sufferers of rheumatoid arthritis have faced similar difficulties.

Start your day with The Independent, sign up for daily news emails
Latest stories from i100
Have you tried new the Independent Digital Edition apps?
Independent Dating
and  

By clicking 'Search' you
are agreeing to our
Terms of Use.

iJobs Job Widget
iJobs General

Guru Careers: Software Developer / C# Developer

£40-50K: Guru Careers: We are seeking an experienced Software / C# Developer w...

Guru Careers: Software Developer

£35 - 40k + Benefits: Guru Careers: We are seeking a Software Developer (JavaS...

SThree: Trainee Recruitment Consultant / Resourcer

£18000 - £23000 per annum + Commission: SThree: As a Trainee Recruitment Consu...

Ashdown Group: UI Developer - (UI, HTML, CSS, JavaScript, AngularJS)

£25000 - £40000 per annum: Ashdown Group: UI Developer - (UI, JavaScript, HTML...

Day In a Page

Sun, sex and an anthropological study: One British academic's summer of hell in Magaluf

Sun, sex and an anthropological study

One academic’s summer of hell in Magaluf
From Shakespeare to Rising Damp... to Vicious

Frances de la Tour's 50-year triumph

'Rising Damp' brought De la Tour such recognition that she could be forgiven if she'd never been able to move on. But at 70, she continues to flourish - and to beguile
'That Whitsun, I was late getting away...'

Ian McMillan on the Whitsun Weddings

This weekend is Whitsun, and while the festival may no longer resonate, Larkin's best-loved poem, lives on - along with the train journey at the heart of it
Kathryn Williams explores the works and influences of Sylvia Plath in a new light

Songs from the bell jar

Kathryn Williams explores the works and influences of Sylvia Plath
How one man's day in high heels showed him that Cannes must change its 'no flats' policy

One man's day in high heels

...showed him that Cannes must change its 'flats' policy
Is a quiet crusade to reform executive pay bearing fruit?

Is a quiet crusade to reform executive pay bearing fruit?

Dominic Rossi of Fidelity says his pressure on business to control rewards is working. But why aren’t other fund managers helping?
The King David Hotel gives precious work to Palestinians - unless peace talks are on

King David Hotel: Palestinians not included

The King David is special to Jerusalem. Nick Kochan checked in and discovered it has some special arrangements, too
More people moving from Australia to New Zealand than in the other direction for first time in 24 years

End of the Aussie brain drain

More people moving from Australia to New Zealand than in the other direction for first time in 24 years
Meditation is touted as a cure for mental instability but can it actually be bad for you?

Can meditation be bad for you?

Researching a mass murder, Dr Miguel Farias discovered that, far from bringing inner peace, meditation can leave devotees in pieces
Eurovision 2015: Australians will be cheering on their first-ever entrant this Saturday

Australia's first-ever Eurovision entrant

Australia, a nation of kitsch-worshippers, has always loved the Eurovision Song Contest. Maggie Alderson says it'll fit in fine
Letterman's final Late Show: Laughter, but no tears, as David takes his bow after 33 years

Laughter, but no tears, as Letterman takes his bow after 33 years

Veteran talkshow host steps down to plaudits from four presidents
Ivor Novello Awards 2015: Hozier wins with anti-Catholic song 'Take Me To Church' as John Whittingdale leads praise for Black Sabbath

Hozier's 'blasphemous' song takes Novello award

Singer joins Ed Sheeran and Clean Bandit in celebration of the best in British and Irish music
Tequila gold rush: The spirit has gone from a cheap shot to a multi-billion pound product

Join the tequila gold rush

The spirit has gone from a cheap shot to a multi-billion pound product
12 best statement wallpapers

12 best statement wallpapers

Make an impact and transform a room with a conversation-starting pattern
Paul Scholes column: Does David De Gea really want to leave Manchester United to fight it out for the No 1 spot at Real Madrid?

Paul Scholes column

Does David De Gea really want to leave Manchester United to fight it out for the No 1 spot at Real Madrid?